Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.28, expectations were $-0.34. Operator: Hello. Thank you for standing by ...

Q4 2024 Earnings Call Transcript March 13, 2025 REGENXBIO Inc. beats earnings expectations. Reported EPS is $-1.01, expectations were $-1.27. Operator: Welcome everyone to the Fourth Quarter and Year ...

Additionally, Unity Biotechnology also announced 3 Yehia Hashad, MD, executive vice president of research and development and ...